Literature DB >> 11976000

Anaerobic treatment of pinkwater in a fluidized bed reactor containing GAC.

Stephen W Maloney1, Neal R Adrian, Robert F Hickey, Robert L Heine.   

Abstract

Pinkwater is generated during the handling and demilitarization of conventional explosives. This listed hazardous waste contains dissolved trinitrotoluene (TNT) and cyclo trimethylene trinitramine (RDX), as well as some by-products. It represents the largest quantity of hazardous waste generated by the operations support command, and its treatment produces a by-product hazardous waste--spent granular activated carbon (GAC). Anaerobic treatment in a fluidized bed reactor (FBR) containing GAC is an emerging technology for organic compounds resistant to aerobic biological treatment. Bench scale batch studies using an anaerobic consortium of bacteria fed ethanol as the sole electron donor demonstrated the transformation of TNT to triaminotoluene (TAT), which then degrades to undetectable end products. RDX is sequentially degraded to nitroso-, dinitroso-, trinitroso- and hydroxylaminodinitroso-RDX before the triazine ring is presumably cleaved, forming methanol and formaldehyde as major end products. The bacterial members of the anaerobic consortia are typically found in sludge digesters at municipal or industrial wastewater treatment plants. The results of a pilot scale evaluation of this process that was conducted at McAlester Army Ammunition Plant (MCAAP, OK) over a 1 year period are reported in this paper. The pilot test experienced wide fluctuations in influent concentrations, representative of true field conditions. The FBR was a 20 in. (51 cm) diameter column with an overall height of 15 ft (4.9 m) and a bed of GAC occupying 11 ft (3.4m). Water was recirculated through the column continuously at 30 gpm (114 l/min) to keep the GAC fluidized, and pinkwater for treatment was pumped into the recirculation line. Several flowrates were evaluated to determine the proper mass loading rate (mass of TNT and RDX per reactor volume per time, kg/m(3) per day) which the reactor could handle while meeting the discharge limitations. Based on the tests performed, a 1 gpm (3.785 l/min) rate in the 188 gal (710 l) volume of the fluidized GAC bed was determined to consistently meet the discharge requirements. This information was used to develop a cost estimate for a system capable of treating the total effluent currently produced at MCAAP. The cost of installing and operating this system was compared to the cost of GAC adsorption for MCAAP at current pinkwater generation rates. The GAC-FBR system had an annual operating cost of approximately US$ 19K, compared to US$ 71 K annually for GAC adsorption. When including the amortization of the capital equipment required for the GAC-FBR, the payback period for installation of this new process was estimated at 3.7 years.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976000     DOI: 10.1016/s0304-3894(01)00375-2

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  4 in total

1.  Aerobic biodegradation of 2,4,6-trinitrotoluene (TNT) by Bacillus cereus isolated from contaminated soil.

Authors:  H Aysun Mercimek; Sadık Dincer; Gulcihan Guzeldag; Aysenur Ozsavli; Fatih Matyar
Journal:  Microb Ecol       Date:  2013-05-29       Impact factor: 4.552

2.  Transformation of RDX and other energetic compounds by xenobiotic reductases XenA and XenB.

Authors:  Mark E Fuller; Kevin McClay; Jalal Hawari; Louise Paquet; Thomas E Malone; Brian G Fox; Robert J Steffan
Journal:  Appl Microbiol Biotechnol       Date:  2009-05-20       Impact factor: 4.813

3.  Effects of granular activated carbon and Fe-modified granular activated carbon on anammox process start-up.

Authors:  Guangsong Lu; Yunqian Ma; Lihua Zang; Yan Sun; Fei Yu; Rong Xue
Journal:  RSC Adv       Date:  2021-03-12       Impact factor: 3.361

4.  Post-treatment of secondary wastewater treatment plant effluent using a two-stage fluidized bed bioreactor system.

Authors:  Golam Hossein Safari; Kaan Yetilmezsoy; Amir Hossein Mahvi; Mansur Zarrabi
Journal:  J Environ Health Sci Eng       Date:  2013-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.